Effects of tethered ligands and of metal oxidation state on the interactions of cobalt complexes with the 26S proteasome
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 105 (12) , 1759-1766
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Metals in anticancer therapy: Copper(II) complexes as inhibitors of the 20S proteasomeEuropean Journal of Medicinal Chemistry, 2009
- Synthesis, characterization and biological activities of mononuclear Co(III) complexes as potential bioreductively activated prodrugsJournal of Inorganic Biochemistry, 2009
- Comparative Activities of Nickel(II) and Zinc(II) Complexes of Asymmetric [NN′O] Ligands as 26S Proteasome InhibitorsInorganic Chemistry, 2009
- Proteasome inhibitors: Poisons and remediesMedicinal Research Reviews, 2007
- The Therapeutic Potential of Gallium-Based Complexes in Anti-Tumor Drug DesignLetters in Drug Design & Discovery, 2007
- 20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug DevelopmentChemical Reviews, 2007
- Synthesis, Structure, and Anticancer Activity of Gallium(III) Complexes with Asymmetric Tridentate Ligands: Growth Inhibition and Apoptosis Induction of Cisplatin-Resistant Neuroblastoma CellsInorganic Chemistry, 2006
- Global approaches to understanding ubiquitinationGenome Biology, 2005
- Proteasome inhibitors: from research tools to drug candidatesChemistry & Biology, 2001
- Ubiquitin, proteasomes, and the regulation of intracellular protein degradationCurrent Opinion in Cell Biology, 1995